Interactive Data Visualization Tool Connects Scientists Worldwide with Vital COVID-19 Research Data
By HospiMedica International staff writers Posted on 01 Jul 2020 |
Image: Zoic Labs’ visualization tool (Photo courtesy of Zoic Labs LLC)
An interactive data visualization tool connecting scientists with critical research while they work towards a cure for COVID-19 could quicken the pace of vital global scientific collaboration amidst the pandemic.
The tool for advanced data visualization on a series of scientific papers has been developed by Zoic Labs LLC (Dr. Culver City, CA, USA) which has implemented rich visual interactivity to allow global scientists dynamic ways to visually connect with the research. The innovative visualization and collaboration tool allows scientists around the world to share their findings and characterizes critical connections between the 27 SARS-CoV-2 proteins and the 332 human genes they interact with, lending a wealth of information about each gathered through research. The tool also provides in-depth knowledge about all current drug interactions and their statuses, and links to external sources for additional information about the virus proteins.
Zoic Labs has incorporated three additional disparate data sets to the existing map, which enabled interactively sharing information across five data sets. The new research characterizes the differences between normal SARS-CoV-2 infected cell signaling and phosphorylation dynamics, allowing a better understanding of the cellular pathways the virus needs to survive. Coupled with its SARS-CoV-2 protein-protein-interaction network, Zoic Labs’ visualization tool could be helpful in understanding the virus on a molecular level.
Related Links:
Zoic Labs LLC
The tool for advanced data visualization on a series of scientific papers has been developed by Zoic Labs LLC (Dr. Culver City, CA, USA) which has implemented rich visual interactivity to allow global scientists dynamic ways to visually connect with the research. The innovative visualization and collaboration tool allows scientists around the world to share their findings and characterizes critical connections between the 27 SARS-CoV-2 proteins and the 332 human genes they interact with, lending a wealth of information about each gathered through research. The tool also provides in-depth knowledge about all current drug interactions and their statuses, and links to external sources for additional information about the virus proteins.
Zoic Labs has incorporated three additional disparate data sets to the existing map, which enabled interactively sharing information across five data sets. The new research characterizes the differences between normal SARS-CoV-2 infected cell signaling and phosphorylation dynamics, allowing a better understanding of the cellular pathways the virus needs to survive. Coupled with its SARS-CoV-2 protein-protein-interaction network, Zoic Labs’ visualization tool could be helpful in understanding the virus on a molecular level.
Related Links:
Zoic Labs LLC
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans